The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Research Foundation Funding Leads to New Measurement Tool for RA

Rheumatology Research Foundation Funding Leads to New Measurement Tool for RA

August 13, 2017 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A new measurement tool could mean big changes for the treatment of rheumatoid arthritis (RA). With funding from the Rheumatology Research Foundation, Gregg Silverman, MD, led a study that developed a means for the measurement of immunologic memory in autoimmune disease. This new tool will allow rheumatologists and investigators to measure the immunologic defects that are the actual cause of a patient’s RA and evaluate the effectiveness of treatment.

You Might Also Like
  • Rheumatology Research Foundation Funding Enables Potential Treatment Advancements
  • Rheumatology Research Foundation Funding Aids Researcher’s Career
  • The ACR, Rheumatology Research Foundation Address Research Funding Shortfall
Explore This Issue
August 2017
Also By This Author
  • ACR Praises Congress for Bill with Part B Fix, Therapy Caps Repeal
Dr. Silverman

Dr. Silverman

“The tool developed in our Foundation-funded project measures the immunologic defects that actually cause rheumatoid arthritis. By measuring the number of autoimmune B cells in someone’s immunologic memory, we can now look at the underlying cause of the disease and evaluate the effectiveness of treatment,” says Dr. Silverman, professor of medicine and pathology at NYU Langone Medical Center. “This information provides investigators with the street signs they need to see if they are on the right track toward developing a cure. It can be applied to evaluate new, as well as existing, RA medications, which can help guide the development of a cure or the treatment of individual patients. It also can be adapted to measure other diseases caused by problems with B cell autoimmune memory, such as lupus.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Silverman’s work was funded in part by the Foundation’s Innovative Research Award. The award provides independent investigators with the funding they need to pursue ideas that could lead to breakthroughs in discovering new treatments and cures. Dr. Silverman says the funding was crucial to the project. “The funding that I received from the Foundation allowed my team to develop this new tool, which we hope will improve the way investigators search for a cure.”

The impact of Dr. Silverman’s work could benefit patients, investigators and physicians by providing new avenues for testing and treating the disease itself, as opposed to combatting symptoms alone. “Being a practicing rheumatologist, I am very concerned about the welfare of my patients, and I believe we can’t be complacent. We have to keep working toward better treatments and a cure,” says Dr. Silverman. “That is what this study is all about, and that is what the Rheumatology Research Foundation is all about.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The study, “Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission,” was published in Arthritis & Rheumatology in June.

Filed Under: Conditions, From the College, Rheumatoid Arthritis Tagged With: Autoimmune disease, effectiveness, immunologic memory, measurement, Research, Rheumatoid arthritis, rheumatology, Rheumatology Research Foundation, tool, TreatmentIssue: August 2017

You Might Also Like:
  • Rheumatology Research Foundation Funding Enables Potential Treatment Advancements
  • Rheumatology Research Foundation Funding Aids Researcher’s Career
  • The ACR, Rheumatology Research Foundation Address Research Funding Shortfall
  • Rheumatology Research Foundation to Play Role in Developing New RA, Lupus Treatments

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.